Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

INMB

Inmune Bio, Inc.

CIK 0001711754 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.79
↑ 0.07 (4.07%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Options

Key stats

Market Cap
$47.59M
P/E Ratio
-1.14
EPS
-1.86
Dividend Yield
Not covered
52W Position
32%
Beta
2.54

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.43
P/S
Not covered
EV/Revenue
Not covered
ROE
-212.0%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 32%
$1.09$3.24

Latest Financials

2025-12-31 FY
Revenue
$50.00K
Net Income
-$45.93M
Total Assets
$32.35M
Free Cash Flow
-$23.62M

Recent news